Why the study?
Are anti-myocardial antibodies pathogenically important in the evolution of dilated or chagasic myocardiopathies?
Are anti-myocardial antibodies pathogenically important in the evolution of dilated or chagasic myocardiopathies?
The absence of immunoglobulin and complement deposition in myocardial biopsies does not support the pathogenic role of anti-myocardial antibodies in dilated or chagasic cardiomyopathies.
Answers are grounded in this paper and cite their sources.
Does not support pathogenic role of anti-myocardial antibodies in cardiomyopathies; hypothesis-generating and should not change practice.
Right ventricular endomyocardial biopsies were studied in 30 patients, 15 with myocardiopathy from chronic Chagas'disease and 15 with idiopathic congestive myocardiopathy; five other myocardial samples were taken at necropsies of patients with chronic Chagas' disease. The authors tried to establish by means of direct immunofluorescence techniques whether there were immunoglobulins G, A and M, fibrinogen and C3 complement deposition in the myocardium; only one of these 30 patients exhibited a positive reaction to IgG, it was a patient with idiopathic congestive myocardiopathy. All fragments from patients with Chagas' disease showed no response to any of the fluorescent conjugates. These findings do not support the idea that anti-myoeardial antibodies have pathogenic importance in the evolution of dilated or chagasic myocardiopathies.
No takes yet. Share an insight, caveat, or question.
Higuchi et al. (1986) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: